Davutamig

Modify Date: 2024-01-09 12:06:48

Davutamig structure	Common Name	Davutamig
	CAS Number	2648058-48-2	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Davutamig

Davutamig (REGN-5093) is a humanized immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic[1].

Properties
Spectrum

Name	Davutamig

Description	Davutamig (REGN-5093) is a humanized immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR
References	[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.

No Any Chemical & Physical Properties

Davutamig

Use of Davutamig

Names

Davutamig Biological Activity

Chemical & Physical Properties